Publications

• Holstein E-M, Clark KRM, Lydall DA. Interplay between Nonsense-Mediated mRNA Decay and DNA Damage Response Pathways Reveals that Stn1 and Ten1 Are the Key CST Telomere-Cap Components. Cell Reports 2014, 7(4), 1259-1269.
• Holstein EM, Lydall David. Quantitative amplification of single-stranded DNA (QAOS). 2012.
• Weile J, Pocock M, Cockell SJ, Lord P, Dewar JM, Holstein EM, Wilkinson D, Lydall D, Hallinan J, Wipat A. Customizable views on semantically integrated networks for systems biology. Bioinformatics 2011, 27(9), 1299-1306.
• Addinall SG, Holstein EM, Lawless C, Yu M, Chapman K, Banks AP, Ngo HP, Maringele L, Taschuk M, Young A, Ciesiolka A, Lister AL, Wipat A, Wilkinson DJ, Lydall D. Quantitative Fitness Analysis Shows That NMD Proteins and Many Other Protein Complexes Suppress or Enhance Distinct Telomere Cap Defects. PLoS Genetics 2011, 7(4), e1001362.
• Holstein E-M, Lawless C, Banks P, Lydall D. Genome-wide Quantitative Fitness Analysis (QFA) of yeast cultures. In: Marco Muzi-Falconi, Grant W Brown, ed. Genome Instability: Methods and Protocols. New York: Humana Press Inc, 2018, pp.575-597.
• Holstein EM, Ngo G, Lawless C, Banks P, Greetham M, Wilkinson D, Lydall D. Systematic Analysis of the DNA Damage Response Network in Telomere Defective Budding Yeast. G3: Genes, Genomes, Genetics 2017, 7(7), 2375-2389.
• Rennie KJ, OHara J, Rousseau NS, Stocken DD, Howel D, Ternent L, Drinnan M, Bray A, Rooshenas L, Hamilton DW, Steel A, Fouweather T, Hynes A-M, Holstein E-M, Oluboyede Y, Abouhajar A, Wilson JA, Carrie S. Nasal Airway Obstruction Study (NAIROS): a phase III, open label, mixed methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal deviation with nasal obstruction. BMC Trials 2020, 21(1), 179.
• Kunadian V, Chan D, Ali H, Wilkinson N, Howe N, McColl E, Thornton J, von Wilamowitz-Moellendorff A, Holstein EM, Burns G, Fisher A, Stocken D, De Soyza A. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronicobstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2). BMJ Open 2018, 8, e020713.